Lewy body dementia: When it isn’t Alzheimer’s (Speaker’s name here)
Dementia with Lewy Bodies: What is it and how do I treat it ?
-
Upload
angelina-ebrill -
Category
Documents
-
view
39 -
download
1
description
Transcript of Dementia with Lewy Bodies: What is it and how do I treat it ?
![Page 1: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/1.jpg)
Dementia with Lewy Bodies:Dementia with Lewy Bodies:What is it and how do I treat it ? What is it and how do I treat it ?
James B. Leverenz, M.D.James B. Leverenz, M.D.
Departments of Departments of Neurology and Psychiatry and Behavioral SciencesNeurology and Psychiatry and Behavioral Sciences
University of Washington School of Medicine University of Washington School of Medicine
andandVA Northwest Network Mental Illness and Parkinson’s VA Northwest Network Mental Illness and Parkinson’s
Disease Research, Education, and Clinical CenterDisease Research, Education, and Clinical Centers
![Page 2: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/2.jpg)
How do you define a “disease” ?How do you define a “disease” ?
• Genetics > Pathology > Clinical ?Genetics > Pathology > Clinical ?
» mutation causes pathology leading to the clinical mutation causes pathology leading to the clinical presentationpresentation
• What about known pathogens ?What about known pathogens ?
» e.g. syphilis, mad cow disease (exposuree.g. syphilis, mad cow disease (exposure
superimposed on genetic risk).superimposed on genetic risk).
• Becoming difficult to define a “disease”Becoming difficult to define a “disease”
![Page 3: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/3.jpg)
![Page 4: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/4.jpg)
![Page 5: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/5.jpg)
History of Parkinson’s DiseaseHistory of Parkinson’s Disease
138-201 138-201 Galen describes resting tremorGalen describes resting tremor
18171817 Initial description of disease by Initial description of disease by James ParkinsonJames Parkinson
1859/681859/68 Trousseau describes intellectual declineTrousseau describes intellectual decline
1861-951861-95 Charcot and Brissaud emphasize rigidity, Charcot and Brissaud emphasize rigidity, bradykinesia and “psychic troubles”bradykinesia and “psychic troubles”
![Page 6: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/6.jpg)
Clinical SymptomsClinical Symptoms in Parkinson’s Disease in Parkinson’s Disease
• Tremor (resting) Tremor (resting)
• RigidityRigidity
• BradykinesiaBradykinesia
• Postural instabilityPostural instability
![Page 7: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/7.jpg)
Parkinson’s DiseaseParkinson’s Disease
![Page 8: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/8.jpg)
Parkinson’s DiseaseParkinson’s Disease
![Page 9: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/9.jpg)
Pathology in Parkinson’s DiseasePathology in Parkinson’s Disease
• Clinical history of parkinsonismClinical history of parkinsonism
• Neuronal loss and Lewy body Neuronal loss and Lewy body inclusions in the substantia nigra, inclusions in the substantia nigra, locus coeruleus, basal forebrain locus coeruleus, basal forebrain and cerebral cortexand cerebral cortex
![Page 10: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/10.jpg)
Lewy Body InclusionsLewy Body Inclusions
• Characteristic inclusions in substantia nigra neurons of Characteristic inclusions in substantia nigra neurons of patients with Parkinson’s diseasepatients with Parkinson’s disease
• Immunoreactive for neurofilaments, ubiquitin and alpha-Immunoreactive for neurofilaments, ubiquitin and alpha-synuclein, but not tau (NFT are tau and ubiquitin positive)synuclein, but not tau (NFT are tau and ubiquitin positive)
• In substantia nigra it is cytoplasmic, round, eosinophilic with In substantia nigra it is cytoplasmic, round, eosinophilic with clear haloclear halo
• In cortex less distinct appearance, best visualized with In cortex less distinct appearance, best visualized with alpha-synuclein immunohistochemistryalpha-synuclein immunohistochemistry
![Page 11: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/11.jpg)
Pathology in Parkinson’s DiseasePathology in Parkinson’s Disease
![Page 12: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/12.jpg)
Pathology in Parkinson’s DiseasePathology in Parkinson’s Disease
![Page 13: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/13.jpg)
Pathology in Parkinson’s DiseasePathology in Parkinson’s Disease
![Page 14: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/14.jpg)
History of History of Dementia with Lewy BodiesDementia with Lewy Bodies
19611961 First report of cortical LB’s in dementia (Okazaki First report of cortical LB’s in dementia (Okazaki et al)et al)
19741974 Start of clinical reports of parkinsonism in ADStart of clinical reports of parkinsonism in AD
19861986 High frequency of LB in AD patients (Leverenz & High frequency of LB in AD patients (Leverenz & Sumi)Sumi)
19901990 “Lewy body variant” proposed (Hansen et al)“Lewy body variant” proposed (Hansen et al)
19901990 “Diffuse Lewy body disease” (Crystal et al)“Diffuse Lewy body disease” (Crystal et al)
19961996 “Dementia with Lewy bodies” (Consortium on “Dementia with Lewy bodies” (Consortium on DLB)DLB)
![Page 15: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/15.jpg)
Consensus Criteria for Dementia with Lewy BodiesConsensus Criteria for Dementia with Lewy Bodies
1. Progressive cognitive decline with loss of normal 1. Progressive cognitive decline with loss of normal social and occupational function: loss of memory, social and occupational function: loss of memory, attention, frontal subcortical skills, visuospatial attention, frontal subcortical skills, visuospatial abilityability
2. Two of the following:2. Two of the following:
a. fluctuating cognition, attention, alertnessa. fluctuating cognition, attention, alertness
b. visual hallucinationsb. visual hallucinations
c. motor features of parkinsonismc. motor features of parkinsonism
3. Supportive features: falls, syncope, LOC, neuroleptic 3. Supportive features: falls, syncope, LOC, neuroleptic sensitivity, delusions, non-visual hallucinationssensitivity, delusions, non-visual hallucinations
![Page 16: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/16.jpg)
Consensus Criteria for Consensus Criteria for Dementia with Lewy BodiesDementia with Lewy Bodies
““It is suggested that if dementia occurs It is suggested that if dementia occurs within 12 within 12 monthsmonths of the onset of extrapyramidal motor of the onset of extrapyramidal motor symptoms, the patient should be assigned a symptoms, the patient should be assigned a primary diagnosis of primary diagnosis of possible DLBpossible DLB … “ … “
““If the clinical history of parkinsonism is If the clinical history of parkinsonism is longer longer than 12 monthsthan 12 months, , PD with dementiaPD with dementia … will … will usually be a more appropriate diagnostic label usually be a more appropriate diagnostic label …”…”
![Page 17: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/17.jpg)
Consensus Criteria for Consensus Criteria for Dementia with Lewy BodiesDementia with Lewy Bodies
• Criteria good predictor of Lewy body Criteria good predictor of Lewy body pathology (with or without concomitant AD pathology (with or without concomitant AD pathology) - pathology) - high positive predictive valuehigh positive predictive value
• Criteria poor predictor of the absence of Lewy Criteria poor predictor of the absence of Lewy body body pathology - pathology - low negative predictive valuelow negative predictive value
![Page 18: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/18.jpg)
Lewy Body Frequency in Alzheimer’s DiseaseLewy Body Frequency in Alzheimer’s Disease
19861986 28% of AD (Leverenz and Sumi)28% of AD (Leverenz and Sumi)
19871987 55% of AD (Ditter and Mirra)55% of AD (Ditter and Mirra)
19951995 21% in CERAD registry (Hulette et al)21% in CERAD registry (Hulette et al)
1998 1998 23% in community based series (Lim et 23% in community based series (Lim et al)al)
19961996 Dementia with Lewy bodies, Dementia with Lewy bodies, largest largest pathological subgroup after pure ADpathological subgroup after pure AD
(Consortium on DLB)(Consortium on DLB)
![Page 19: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/19.jpg)
Lewy Body Frequency in Alzheimer’s DiseaseLewy Body Frequency in Alzheimer’s Disease
• 1998 to 20001998 to 2000
» Using ASN immunohistochemistry and Using ASN immunohistochemistry and amygdala samplingamygdala sampling
» 63% PS-1/APP mutation AD63% PS-1/APP mutation AD
» 50% of Down syndrome50% of Down syndrome
» 61% of “sporadic” AD61% of “sporadic” AD
» 64% PS-2 mutation AD64% PS-2 mutation AD
![Page 20: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/20.jpg)
![Page 21: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/21.jpg)
Lewy Body Frequency in Alzheimer’s DiseaseLewy Body Frequency in Alzheimer’s Disease
• 20032003
» 33 % of AD cases in a community-33 % of AD cases in a community-based samplebased sample
alpha-synuclein stainingalpha-synuclein staining
amygdala samplingamygdala sampling
• There appears to be a sampling-There appears to be a sampling-bias in the frequency of LB bias in the frequency of LB pathologypathology
![Page 22: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/22.jpg)
Consensus Criteria for Dementia with Lewy BodiesConsensus Criteria for Dementia with Lewy Bodies
PathologyPathology
• Essential for diagnosis of DLBEssential for diagnosis of DLB
» Lewy bodiesLewy bodies
• Associated but not essentialAssociated but not essential
» Lewy-related neuritesLewy-related neurites
» Plaques (all morphologic types)Plaques (all morphologic types)
» Neurofibrillary tanglesNeurofibrillary tangles
» Regional neuronal loss (substantia nigra, locus coeruleus, Regional neuronal loss (substantia nigra, locus coeruleus, basal forebrain)basal forebrain)
» Microvacuolation and synapse lossMicrovacuolation and synapse loss
» Neurochemical abnormalities and neurotransmitter deficitsNeurochemical abnormalities and neurotransmitter deficits
![Page 23: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/23.jpg)
Pathology in Pathology in Dementia with Lewy BodiesDementia with Lewy Bodies
• Neuronal loss and LB’s in substantia nigraNeuronal loss and LB’s in substantia nigra
• Cortical LB’s and CA-2 ubiquitinated fibersCortical LB’s and CA-2 ubiquitinated fibers
• Full AD pathology (SP/NFT), ~ 80%Full AD pathology (SP/NFT), ~ 80%
• Restricted AD pathology (diffuse SP and restricted Restricted AD pathology (diffuse SP and restricted NFT distribution), ~ 20%NFT distribution), ~ 20%
![Page 24: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/24.jpg)
Pathology in Pathology in Dementia with Lewy BodiesDementia with Lewy Bodies
Substantia nigra
![Page 25: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/25.jpg)
Pathology in Pathology in Dementia with Lewy BodiesDementia with Lewy Bodies
Substantia nigra
![Page 26: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/26.jpg)
Pathology in Pathology in Dementia with Lewy BodiesDementia with Lewy Bodies
CerebralCerebralCortex Cortex
![Page 27: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/27.jpg)
Pathology in Pathology in Dementia with Lewy BodiesDementia with Lewy Bodies
HippocampalHippocampalCA-2 NeuritesCA-2 Neurites
![Page 28: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/28.jpg)
Pathology in Pathology in Dementia with Lewy BodiesDementia with Lewy Bodies
AmygdalaAmygdala
![Page 29: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/29.jpg)
The Clinical Diagnosis of The Clinical Diagnosis of Dementia with Lewy Bodies Dementia with Lewy Bodies
![Page 30: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/30.jpg)
Consensus Criteria for Dementia with Lewy BodiesConsensus Criteria for Dementia with Lewy Bodies
1. Progressive cognitive decline with loss of normal 1. Progressive cognitive decline with loss of normal social and occupational function: loss of memory, social and occupational function: loss of memory, attention, frontal subcortical skills, visuospatial attention, frontal subcortical skills, visuospatial abilityability
2. Two of the following:2. Two of the following:
a. fluctuating cognition, attention, alertnessa. fluctuating cognition, attention, alertness
b. visual hallucinationsb. visual hallucinations
c. motor features of parkinsonismc. motor features of parkinsonism
3. Supportive features: falls, syncope, LOC, neuroleptic 3. Supportive features: falls, syncope, LOC, neuroleptic sensitivity, delusions, non-visual hallucinationssensitivity, delusions, non-visual hallucinations
![Page 31: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/31.jpg)
Clinical Signs and Symptoms in DLBClinical Signs and Symptoms in DLB
• Early psychiatric symptomsEarly psychiatric symptoms
» Visual hallucinations, complex delusionsVisual hallucinations, complex delusions
• ParkinsonismParkinsonism
» Early gait and posture/stance difficultiesEarly gait and posture/stance difficulties
» Tremor less frequentTremor less frequent
» May never be clinically evidentMay never be clinically evident
![Page 32: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/32.jpg)
Clinical Signs and Symptoms in DLBClinical Signs and Symptoms in DLB
• CognitionCognition
» Short-term memory lossShort-term memory loss
» Cortical dysfunctionCortical dysfunction
» Greater insightGreater insight
• Neuroleptic sensitivityNeuroleptic sensitivity
![Page 33: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/33.jpg)
Clinical Signs and Symptoms in DLBClinical Signs and Symptoms in DLB
• ExaminationExamination
» Gait evaluation (arm swing, posture, Gait evaluation (arm swing, posture, postural stabilitypostural stability
» Frontal release signs (snout, glabellar, Frontal release signs (snout, glabellar, palmomental)palmomental)
• TestingTesting
» standard dementia w/ustandard dementia w/u
![Page 34: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/34.jpg)
0.0
0.2
0.4
0.6
0.8
1.0
Sensitivity Specificity PPV NPV
PsychosisHallucinationsDelusionsParkinsonismParkinsonism + Psychosis
Diagnostic Accuracy in a Diagnostic Accuracy in a Community-Based Sample of DLBCommunity-Based Sample of DLB
![Page 35: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/35.jpg)
Case Clinical Characteristics Neuropathology2
Parkinsonism Hallucinations1 Braak Stage LB Pathology
NFT SP SN Amygdala
1 - - V C - +2 + VH V C + +3 - - V C + +4 + Present V C + +5 + Present III C + +6 + VH III B + +7 - Present V C + +8 - - III B - +9 - Present III B + +10 - Present V C + +
1 VH = Visual hallucinations; Present = Hallucinations present, type not specified2 CERAD criteria used for AD neuropathological diagnosis
Diagnostic Accuracy in a Diagnostic Accuracy in a Community-Based Sample of DLBCommunity-Based Sample of DLB
![Page 36: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/36.jpg)
Treatment of Dementia with Lewy Bodies:Treatment of Dementia with Lewy Bodies:Cholinesterase InhibitorsCholinesterase Inhibitors
![Page 37: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/37.jpg)
Major Changes in the CholinergicMajor Changes in the CholinergicSystem in Alzheimer’s DiseaseSystem in Alzheimer’s Disease
• Depletion of acetylcholine (ACh)Depletion of acetylcholine (ACh)
• Decline in choline acetyltransferase (ChAT) activityDecline in choline acetyltransferase (ChAT) activity
• Loss of cholinergic neuronsLoss of cholinergic neurons
Acetylcholinesterase (AChE)Acetylcholinesterase (AChE)
Butyrylcholinesterase (BuChE)Butyrylcholinesterase (BuChE)
• Alterations in nicotinic/muscarinic receptorsAlterations in nicotinic/muscarinic receptors
![Page 38: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/38.jpg)
FC = Frontal cortexPC = Parietal cortexOC = Occipital cortexH = HippocampusB = Nucleus basalisS = Medial septal nucleus
Adapted from Coyle JT, et al. Science. 1983;219:1184-1190.
Cholinergic System Innervates Areas Cholinergic System Innervates Areas Associated With Memory and LearningAssociated With Memory and Learning
FC
PC
BH
OCS
![Page 39: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/39.jpg)
Cholinergic Enhancement StrategiesCholinergic Enhancement Strategies
• Analogous to dopaminergic enhancement strategies for Parkinson's disease
• Cholinesterase inhibitor therapy
» inhibits AChE (BuChE-tacrine/rivastigmine), degradative enzyme for acetylcholine
» results in increase of acetylcholine available to postsynaptic neurons
» increases cholinergic neurotransmission
![Page 40: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/40.jpg)
ACh = acetylcholine; AChE = acetylcholinesterase; BuChE = butyrylcholinesterase; ChAT = choline acetyltransferase; CoA = coenzyme A.
Adapted from Adem A. Acta Neurol Scand. 1992;85(suppl 139):69-74.
AChE
AcetylCoA
CholineCholineACh
Presynaptic Presynaptic neuronneuron
Synaptic cleftSynaptic cleft
PostsynapticPostsynapticneuronneuron
Cholinergic receptorCholinergic receptor
AcetateAcetate
CholineCholineCholine+
++
AstrocyteAstrocyte
ACh
AChE
BuChEBuChE
BuChEBuChE
ChAT
Normal Cholinergic FunctionNormal Cholinergic Function
![Page 41: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/41.jpg)
Effect of Tacrine on Cognition:Effect of Tacrine on Cognition:ADAS-Cog*ADAS-Cog*
*Alzheimer’s Disease Assessment Scale–Cognitive Subscale†P<0.001 vs placebo; ‡Observed mean treatment difference. Evaluable patients at week 30 = 263.Knapp MJ, et al, for the Tacrine Study Group. JAMA. 1994;271:985-991.
––33
11
00
22
33
––11
––22
Mea
n C
h an g
e fr
om B
a se l
ine
Mea
n C
h ang
e f r
o m B
a se l
ine
BaselineBaseline
WeeksWeeks30301818 2424121266
160 mg/d (n=238)160 mg/d (n=238)120 mg/d (n=174)120 mg/d (n=174)80 mg/d (n=60)80 mg/d (n=60)Placebo (n=181)Placebo (n=181)
BaselineBaseline
ImproveImprove
DeclineDecline
††
4.14.1‡‡
![Page 42: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/42.jpg)
Is There a Cholinergic Deficit in DLB ?Is There a Cholinergic Deficit in DLB ?
• Depletion of acetylcholine (ACh) Depletion of acetylcholine (ACh) ??
• Decline in choline acetyltransferase (ChAT) activity Decline in choline acetyltransferase (ChAT) activity
• Loss of cholinergic neurons Loss of cholinergic neurons
Acetylcholinesterase (AChE) Acetylcholinesterase (AChE) ??
Butyrylcholinesterase (BuChE) Butyrylcholinesterase (BuChE) ??
• Alterations in nicotinic/muscarinic receptors Alterations in nicotinic/muscarinic receptors
![Page 43: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/43.jpg)
Is There a Cholinergic Deficit in DLB ?Is There a Cholinergic Deficit in DLB ?
• Samuel et al (JNEN 1997) Samuel et al (JNEN 1997)
» 30% reduction of ChAT in AD30% reduction of ChAT in AD
» 75% reduction of ChAT in DLB75% reduction of ChAT in DLB
• Tiraboschi et al (Arch Psychiat 2002)Tiraboschi et al (Arch Psychiat 2002)
» ChAT preserved in mild ADChAT preserved in mild AD
» ChAT significantly lower in early DLBChAT significantly lower in early DLB
![Page 44: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/44.jpg)
Cholinesterase Inhibitors:Cholinesterase Inhibitors:Treatment of DLBTreatment of DLB
• Multiple positive open-label trials Multiple positive open-label trials (tacrine, donepezil, rivastimine)(tacrine, donepezil, rivastimine)
• McKeith et al (Lancet 2000)McKeith et al (Lancet 2000)
» Double-blinded, 120 patientsDouble-blinded, 120 patients
» Rivastigmine up to 12 mg/dRivastigmine up to 12 mg/d
» Focus on behavioral symptoms using NPIFocus on behavioral symptoms using NPI
![Page 45: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/45.jpg)
Cholinesterase Inhibitors:Cholinesterase Inhibitors:Treatment of DLBTreatment of DLB
• McKeith et al (Lancet 2000)McKeith et al (Lancet 2000)
» NPINPI
– Positive - apathy, indifference, anxiety, Positive - apathy, indifference, anxiety, delusions, hallucinations and aberrant delusions, hallucinations and aberrant motor behaviormotor behavior
– No change - depression, No change - depression, agitation/aggression, irritability, sleepagitation/aggression, irritability, sleep
![Page 46: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/46.jpg)
Cholinesterase Inhibitors:Cholinesterase Inhibitors:Treatment of DLBTreatment of DLB
• McKeith et al (Lancet 2000)McKeith et al (Lancet 2000)
» MMSE trend positive (p = 0.07)MMSE trend positive (p = 0.07)
» Individual cognitive data all “significantly Individual cognitive data all “significantly favoured rivastigmine.” and “...will be favoured rivastigmine.” and “...will be described more fully elsewhere.”described more fully elsewhere.”
![Page 47: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/47.jpg)
Rivastigmine International Lewy Body Rivastigmine International Lewy Body Dementia Trial: Behavioural Changes (NPI)Dementia Trial: Behavioural Changes (NPI)
NPI 10-item Score–Mean Change from Baseline (OC)NPI 10-item Score–Mean Change from Baseline (OC)
-8-8
-7-7
-6-6
-5-5
-4-4
-3-3
-2-2
-1-1
00BaselineBaseline Week 12Week 12 Week 20Week 20
RivastigmineRivastigminePlaceboPlacebo
Impr
ovem
ent
I mp r
o vem
ent
*P<0.01 vs placebo (ANOVA/ANCOVA)McKeith IG, et al. American Academy of Neurology 52nd Annual Meeting. April 29-May 6, 2000. San Diego, California.
*
![Page 48: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/48.jpg)
Treatment of Dementia with Lewy Bodies:Treatment of Dementia with Lewy Bodies:Behavioral DisturbancesBehavioral Disturbances
![Page 49: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/49.jpg)
Treating Behavioral Disturbances in DLBTreating Behavioral Disturbances in DLB
• Cholinesterase inhibitorsCholinesterase inhibitors
» apathy, psychosis in rivastigmine studyapathy, psychosis in rivastigmine study
• Lack of Treatment trialsLack of Treatment trials
» agitationagitation
» psychosispsychosis
![Page 50: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/50.jpg)
Pharmacologic Approaches to Agitation in AD
• Anti-epileptics (mood stabilizers)» valproic acid (Depakote)
» carbamazepine (Tegretol)
• CNS-active beta-blockers» propranolol
• Other approaches» trazodone
» antiandrogens/estrogens
![Page 51: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/51.jpg)
Antipsychotic MedicationsAntipsychotic Medications
• Avoid typical antipsychoticsAvoid typical antipsychotics
• Consider lowering dopaminergic Consider lowering dopaminergic agentsagents
• Atypical agentsAtypical agents
![Page 52: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/52.jpg)
Agents for Psychotic SymptomsAgents for Psychotic Symptoms
AgentAgentHaloperidolHaloperidolThioridazineThioridazineRisperidoneRisperidoneOlanzapineOlanzapineQuetiapineQuetiapineClozapineClozapine
Starting DoseStarting Dose0.5 mg/day0.5 mg/day10-25 mg/day10-25 mg/day0.5-1.0 mg/day0.5-1.0 mg/day2.5 mg/day2.5 mg/day25-50 mg/day25-50 mg/day6.25 mg/day6.25 mg/day
Maximal DoseMaximal Dose2-5 mg/day2-5 mg/day50-100 mg/day50-100 mg/day2-6 mg/day2-6 mg/day2.5-15 mg/day2.5-15 mg/day400 mg/day400 mg/day50 mg/day50 mg/day
![Page 53: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/53.jpg)
Treatment of Dementia with Lewy Bodies:Treatment of Dementia with Lewy Bodies:Motor SymptomsMotor Symptoms
![Page 54: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/54.jpg)
Antiparkinsonian MedicationsAntiparkinsonian Medications
• No prospective treatment trialsNo prospective treatment trials
• Generally less responsive (non-Generally less responsive (non-dopaminergic motor symptoms)dopaminergic motor symptoms)
• Can elect not to treatCan elect not to treat
• L-dopa preferred to agonistsL-dopa preferred to agonists
![Page 55: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/55.jpg)
Pharmacologic Approaches to DLB
• Cholinesterase inhibitors
• Atypical antipsychotics
• Limited dopaminergic agents
• Other approaches» ? AD agitation medications
» ? Vitamin E
» ? Estrogens, NSAIDS, vaccine, BACE inhibitors
![Page 56: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/56.jpg)
DLB: Research DirectionsDLB: Research Directions
• Improvement in clinical diagnosisImprovement in clinical diagnosis» imaging, electrophysiologyimaging, electrophysiology
• Clinical trialsClinical trials» cognition, behavior, motorcognition, behavior, motor
• Clinical-pathologic studiesClinical-pathologic studies
• BiochemistryBiochemistry» ACh, DA, NE, 5HTACh, DA, NE, 5HT
• GeneticsGenetics» familial DLB, risk factors
![Page 57: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/57.jpg)
• Bonner et al ‘03Bonner et al ‘03 (H&E, ASN) (H&E, ASN)» Research sampleResearch sample (25/36, (25/36, 70%70%))
mostly due to high frequency mostly due to high frequency isolated amygdala/brainstem LB isolated amygdala/brainstem LB
» Community-based sampleCommunity-based sample (10/32, (10/32, 31%31%)) non-significant increase of psychosis, EPSnon-significant increase of psychosis, EPS similar sensitivity/specificity to research similar sensitivity/specificity to research
samples (excl. fluctuation)samples (excl. fluctuation)
Clinical-pathologic Studies in DLB:Clinical-pathologic Studies in DLB:Sample BiasSample Bias
![Page 58: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/58.jpg)
Comparison of Research and Community Samples
ResearchSample
CommunitySample
Significance(P-value)
Age at DeathMean (SD)
78.92 (8.47) 83.23 (8.05) 0.038
Duration ofDisease
Mean (SD)12.16 (6.70) 5.86 (2.58) <0.001
GenderM = 20F = 16
M = 11F = 21 0.080
Frequency of E4Allele in LB (+)
cases (CI)0.70 (0.56-0.84) 0.35 (0.14-0.56) 0.007
Braak Stage Mean (SD)
5.20 (0.58) 4.41 (0.95) <0.001
Frequency of LBPathology
LB (+) = 25LB (-) = 11
LB (+) = 10LB (-) = 22 0.002
![Page 59: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/59.jpg)
Frequency of E4 Allele in Researchand Community Samples
0
0.2
0.4
0.6
0.8
1
Frequency of E4 Allele
ResearchSample
CommunitySample
LB (+)
LB (-)
*
* 2=7.17, p=0.007 # 2=8.96, p=0.003
#
![Page 60: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/60.jpg)
Clinical and Pathological Characteristics in AD versus AD with LB (community-based sample)
NP AD (n = 22)
NP AD +LB's(n = 10)
Age at onset – Mean (SD) 77.3 (7.6) 77.4 (8.47)
Age at death – Mean (SD) 83.2 (8.42) 83.3 (7.70)
Duration of Disease – Mean (SD) 5.85 (2.83) 5.9 (2.13)
Mean Braak Stage – Mean (SD) 4.5 (0.91) 4.2 (1.03)
Gender Male Female
715
46
![Page 61: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/61.jpg)
How do you define a “disease” ?How do you define a “disease” ?
• Genetics > Pathology > Clinical ?Genetics > Pathology > Clinical ?
» mutation causes pathology leading to the clinical mutation causes pathology leading to the clinical presentationpresentation
• What about known pathogens ?What about known pathogens ?
» e.g. syphilis, mad cow disease (exposuree.g. syphilis, mad cow disease (exposure
superimposed on genetic risk).superimposed on genetic risk).
• Becoming difficult to define “a disease”Becoming difficult to define “a disease”
![Page 62: Dementia with Lewy Bodies: What is it and how do I treat it ?](https://reader035.fdocuments.us/reader035/viewer/2022062721/568138af550346895da06d5f/html5/thumbnails/62.jpg)
SummarySummary
• What is Dementia with Lewy bodies ?What is Dementia with Lewy bodies ?» Variant of Alzheimer’s diseaseVariant of Alzheimer’s disease
» Variant of Parkinson’s diseaseVariant of Parkinson’s disease
» Clinical syndrome with unique clinical Clinical syndrome with unique clinical presentation and management issuespresentation and management issues
» Common pathology in dementia (30 to 60%)Common pathology in dementia (30 to 60%)
» Additional study needed to fully characterize this Additional study needed to fully characterize this “second-leading” cause of dementia“second-leading” cause of dementia